Daily Assessment of Symptoms – Anxiety
The Daily Assessment of Symptoms – Anxiety (DAS-A) questionnaire was specifically developed to detect reduction of anxiety symptoms in patients with Generalized Anxiety Disorder (GAD) during the first week of treatment. The original version of the instrument was designed for use in clinical trials assessing new pharmaceutical treatments for patients with GAD. The instrument is able to detect symptom changes within 24 hours of treatment. Currently, this is the only GAD specific tool validated to assess symptom improvement sooner than one week following treatment initiation.
References
Further reading
- Morlock, R; Williams, V; Cappelleri, J; Harness, J; Fehnel, S; Endicott, J; Feltner, D (2008). "Development and evaluation of the Daily Assessment of Symptoms – Anxiety (DAS-A) scale to evaluate onset of symptom relief in patients with generalized anxiety disorder". Journal of Psychiatric Research 42 (12): 1024–36. doi:10.1016/j.jpsychires.2007.09.005. PMID 18061206.
- Feltner, Douglas E.; Harness, Jane; Brock, Jerri; Sambunaris, Angelo; Cappelleri, Joseph C.; Morlock, Robert (2009). "Clinical Evaluation of the Daily Assessment of Symptoms-Anxiety (DAS-A): A New Instrument to Assess the Onset of Symptomatic Improvement in Generalized Anxiety Disorder". CNS Neuroscience & Therapeutics 15: 12–8. doi:10.1111/j.1755-5949.2008.00075.x.
This article is issued from Wikipedia - version of the Friday, August 15, 2014. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.